Take­da dou­bles down at Cal­i­for­nia site as it looks to grow rare dis­ease man­u­fac­tur­ing base

Japan­ese drug­mak­er Take­da is look­ing to ramp up the ef­fi­cien­cy of its rare dis­eases man­u­fac­tur­ing, which in­cludes pro­grams for he­mo­phil­ia and Von Wille­brand dis­ease. It …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER